CTNNB1 and breast cancer: Additionally, limonin can inhibit the stemness of breast cancer cells and attenuate adriamycin resistance in adriamycin-resistant breast cancer cells by suppressing the Wnt/beta-catenin pathway and inhibiting MIR216A methylation [36].